DOCSLIB.ORG

Stem Cells: Balancing Resistance and Sensitivity to DNA Damage

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Stem Cells: Balancing Resistance and Sensitivity to DNA Damage TICB-1043; No. of Pages 7 Opinion Stem cells: balancing resistance and sensitivity to DNA damage 1 2,3 1 Julia C. Liu , Paul H. Lerou , and Galit Lahav 1 Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA 2 Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA 3 Department of Medicine, Division of Genetics, Brigham and Women’s Hospital, Boston, MA 02115, USA Embryonic stem cells (ESCs) are known to be very sen- they must block the propagation of mutations to their sitive to DNA damage and undergo rapid apoptosis even progeny cells, because fixed mutations can have long-term after low-damage doses. By contrast, adult stem cells functional consequences including predisposition to malig- show variable sensitivity to damage. Here we describe nancy. On the other hand, stem cells have a responsibility the multiple pathways that have been proposed to affect to maintain existing tissue organization. Here we describe the sensitivity of stem cells to damage, including prox- the current understanding of the DNA damage response in imity to the apoptotic threshold (mitochondrial priming) hESCs, in particular how their sensitivity is maintained and the p53 signaling pathway, through activation of close to the apoptotic threshold. We also discuss the vari- transcription or direct interaction with proapoptotic ability in sensitivity of adult stem cells to DNA damage and proteins in the cytoplasm. We also discuss which cellular propose multiple regulatory networks that may affect the factors might connect mitochondrial priming with plur- sensitivity of adult stem cells in different tissues. ipotency and the potential therapeutic advances that can be achieved by better understanding of the molecular Multiple distinct mechanisms sensitize hESCs to DNA mechanisms leading to sensitivity or resistance of em- damage bryonic or adult stem cells from different tissues. Many studies have shown that hESCs have higher rates of apoptosis after DNA damage than differentiated cells Stem cells must respond appropriately to DNA damage [4–6], yet this phenomenon remains incompletely under- A major component of cellular aging is the detrimental stood. Several distinct mechanisms have been proposed to accumulation of mutations in the cell’s DNA. Mutations explain how the regulatory networks that control apoptosis that facilitate deregulated proliferation or predispose cells might have unique functions in hESCs (Figure 1). Among to acquire further mutations are often associated with the these mediators is the tumor suppressor protein p53. Well development of cancer [1]. Cellular stress, such as DNA known as a regulator of cell fate decisions in somatic cells damage, contributes to the accrual of such deleterious [10], p53 is also induced after various types of DNA damage mutations and therefore cells mount responses to guard in hESCs. Different classes of DNA lesions, including DNA against genomic instability [2]. Different cell types favor double-strand breaks (DSBs) and single-stranded DNA different responses to cellular stress, ranging from cell (ssDNA), can be generated by various damaging agents, cycle arrest and DNA repair to senescence or apoptosis such as g-ray irradiation and UV irradiation, respectively [3]. ESCs, both human (hESCs) and mouse, are known to [11]. Apoptosis of hESCs in response to both DSBs and be acutely sensitive to DNA damage [4–8]. As an important ssDNA was shown to be dependent on p53 [4,5]. However, cell population that gives rise to all of the tissues in the multiple mechanisms have been proposed to explain how body, ESCs are expected to undergo apoptosis after dam- p53 induces the intrinsic (mitochondrial) apoptotic path- age to prevent damaged cells from compromising the ge- way (Box 1) in hESCs, including p53 transcriptional acti- nomic integrity of the population. Conversely, adult stem vation of proapoptotic target genes, direct interaction of cells are more resistant to cell death after DNA damage, p53 with mitochondrial proteins, and p53-mediated trans- possibly to prevent uncontrolled apoptosis that might com- location of the proapoptotic protein Bax. promise tissue and organ structure. However, this resis- p53 activates the transcription of multiple genes in- tance may lead to genomic instability if damage-induced volved in apoptosis, such as BAX, PUMA, NOXA, and mutations are not properly repaired [9]. Hence, stem cells APAF1 [12]. On treatment with the DNA-damaging drug are caught between two opposing needs. On the one hand, etoposide [13], p53 was found to translocate to the nucleus of hESCs and to upregulate PUMA [5]. Independently of its Corresponding author: Lahav, G. ([email protected]). transcriptional activity, p53 can promote apoptosis by Keywords: apoptosis; hESCs; mitochondrial priming; p53. directly interacting with mitochondrial proteins [14]. It 0962-8924/$ – see front matter was shown in hESCs treated with UV irradiation that ß 2014 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.tcb.2014.03.002 p53-dependent apoptosis occurred without transcription of p53 target genes; instead, p53 associated with the mitochondria [4]. It is currently unclear why in some cases p53 acts as a transcription factor whereas in others it Trends in Cell Biology xx (2014) 1–7 1 TICB-1043; No. of Pages 7 Opinion Trends in Cell Biology xxx xxxx, Vol. xxx, No. x ( 2) P rot i ein p53 nte – on ra p ip c ro cr o t (3) Mitochondrial ns n e a in Tr priming ) (1 Pro– Pro- Mitochondria Apoptosis Nucleus e Bax (4) Bax n Golgi TRENDS in Cell Biology Figure 1. Multiple pathways contribute to human embryonic stem cell (hESC) sensitivity to DNA damage. (1) The tumor suppressor protein p53 acts as a transcription factor, upregulating the expression of proapoptotic target genes. The proapoptotic protein products proceed to induce apoptosis via the mitochondrial pathway. (2) p53 can act independently of transcription to directly interact with cytoplasmic proapoptotic and antiapoptotic proteins, thereby promoting apoptosis. (3) High mitochondrial priming, implying a high ratio of proapoptotic to antiapoptotic proteins, maintains hESCs close to the apoptotic threshold. (4) The apoptotic protein Bax is localized in its active conformation at the Golgi apparatus in some hESCs, poised to induce rapid apoptosis after damage-induced translocation to the mitochondria. activates apoptosis through interacting with mitochondri- when transcription was inhibited, suggesting that al- al proteins. The specific mechanism of activation might be though p53 transcriptional activity is functional, it is not dependent on the type of DNA damage, although further required for apoptosis [16]. Differentiated cells showed studies are required to better understand the specific similar induction of apoptotic targets, suggesting that relationship between the type of damage and p53 function p53 transcriptional activity does not distinguish hESCs in hESCs. Recently, the proapoptotic protein Bax was from differentiated cells. Looking further, p53 was ob- shown to be a major activator of apoptosis in hESCs served in the cytoplasm of hESCs and a cytoplasm-confined dependent on p53. Unlike differentiated cells, hESCs were p53 mutant confirmed that cytoplasmic p53 alone is able to found to maintain Bax in its active conformation at the induce apoptosis. However, cytoplasmic p53 was also pres- Golgi apparatus in basal conditions, whereas previously ent in differentiated cells. These results suggest that, Bax activation was thought to be exclusive to apoptotic although p53 signaling appears similar in hESCs and cells [15]. In hESCs damaged with the DNA-damaging differentiated cells, the internal environment of the two drug etoposide, Bax rapidly localizes to the mitochondria cell types may differ, explaining their differential sensitiv- and initiates apoptosis. Although Bax translocation was ity to DNA damage. Indeed, DNA damage sensitivity in shown to be dependent on p53, the exact mechanism hESCs was shown to correlate with a cell-intrinsic proper- generating the translocation remains unclear. Notably, ty termed mitochondrial priming [16]. Mitochondrial prim- the basal level of active Bax varies substantially among ing is determined by the balance between proapoptotic and different hESC lines and is not detectable in the H1 cell antiapoptotic Bcl-2 family proteins and can predict a cell’s line. Nonetheless, H1 cells show the typical hESC sensi- sensitivity to DNA-damaging drugs [17]. It can be mea- tivity to DNA damage [16], suggesting that basally acti- sured via Bcl-2 homology domain 3 (BH3) profiling, which vated Bax is not required for induction of apoptosis, and quantifies the magnitude of mitochondrial outer mem- hence the other mechanisms presented here can be suffi- brane permeabilization (MOMP) on exposure to a panel cient to induce apoptosis (Figure 1). of proapoptotic promiscuously interacting BH3 peptides. The specific mechanisms leading to DNA damage-in- BH3 profiling revealed that hESCs exhibited higher mito- duced apoptosis in hESCs were recently investigated by chondrial priming than their differentiated progeny and simultaneously probing the DNA damage response in hence were closer to the apoptotic threshold [16]. Boosting differentiated cells and comparing it with the response the priming of differentiated cells using ABT-263, an in- in their differentiated progeny [16]. Consistent with previ- hibitor against antiapoptotic Bcl-2 family proteins, led to ous findings, activation of apoptosis
Load more

Recommended publications
  • The Role of Caspase-2 in Regulating Cell Fate
    cells Review The Role of Caspase-2 in Regulating Cell Fate Vasanthy Vigneswara and Zubair Ahmed * Neuroscience and Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham, Birmingham B15 2TT, UK; [email protected] * Correspondence: [email protected] Received: 15 April 2020; Accepted: 12 May 2020; Published: 19 May 2020 Abstract: Caspase-2 is the most evolutionarily conserved member of the mammalian caspase family and has been implicated in both apoptotic and non-apoptotic signaling pathways, including tumor suppression, cell cycle regulation, and DNA repair. A myriad of signaling molecules is associated with the tight regulation of caspase-2 to mediate multiple cellular processes far beyond apoptotic cell death. This review provides a comprehensive overview of the literature pertaining to possible sophisticated molecular mechanisms underlying the multifaceted process of caspase-2 activation and to highlight its interplay between factors that promote or suppress apoptosis in a complicated regulatory network that determines the fate of a cell from its birth and throughout its life. Keywords: caspase-2; procaspase; apoptosis; splice variants; activation; intrinsic; extrinsic; neurons 1. Introduction Apoptosis, or programmed cell death (PCD), plays a pivotal role during embryonic development through to adulthood in multi-cellular organisms to eliminate excessive and potentially compromised cells under physiological conditions to maintain cellular homeostasis [1]. However, dysregulation of the apoptotic signaling pathway is implicated in a variety of pathological conditions. For example, excessive apoptosis can lead to neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease, whilst insufficient apoptosis results in cancer and autoimmune disorders [2,3]. Apoptosis is mediated by two well-known classical signaling pathways, namely the extrinsic or death receptor-dependent pathway and the intrinsic or mitochondria-dependent pathway.
    [Show full text]
  • EMBO Facts & Figures
    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
    [Show full text]
  • PDCD5 Interacts with P53 and Functions As a Regulator of P53 Dynamics in the DNA Damage Response
    i \Zhuge-BJ" | 2018/6/13 | 5:45 | page 1 | #1 i i i Biophysical Journal Volume: 00 Month Year 1{12 1 PDCD5 interacts with p53 and functions as a regulator of p53 dynamics in the DNA damage response Changjing Zhugea, Xiaojuan Sunb, Yingyu Chenc, Jinzhi Leid a College of Sciences, Beijing Forestry University, 35 Tsinghua East Road, Beijing 100083, China; b School of Science, Beijing University of Posts and Telecommunications, 10 Xitucheng Road, Beijing 100876, China; c Laboratory of Medical Immunology, School of Basic Medical Science, Peking University, 38 Xueyuan Road, Beijing 100083, China; d MOE Key Laboratory of Bioinformatics, Zhou Pei-Yuan Center for Applied Mathematics, Tsinghua University, Beijing 100084, China Abstract The tumor suppressor p53 plays a central role in cell fate decisions after DNA damage. Programmed Cell Death 5 (PDCD5) is known to interact with the p53 pathway to promote cell apoptosis. Recombinant human PDCD5 can significantly sensitize different cancers to chemotherapies. In the present paper, we construct a computational model that includes PDCD5 interactions in the p53 signaling network and study the effects of PDCD5 on p53- mediated cell fate decisions during the DNA damage response. Our results revealed that PDCD5 functions as a co-activator of p53 that regulates p53-dependent cell fate decisions via the mediation of p53 dynamics. The effects of PDCD5 are dose-dependent such that p53 can display either sustained or pulsed dynamics at different PDCD5 levels. Moreover, PDCD5 regulates caspase-3 activation via two mechanisms during the two phases of sustained and pulsed p53 dynamics. This study provides insights regarding how PDCD5 functions as a regulator of the p53 pathway and might be helpful for increasing our understanding of the molecular mechanisms by which PDCD5 can be used to treat cancers.
    [Show full text]
  • DNA Damage Response Pathways in the Nematode C. Elegans
    Cell Death and Differentiation (2004) 11, 21–28 & 2004 Nature Publishing Group All rights reserved 1350-9047/04 $25.00 www.nature.com/cdd Review Death and more: DNA damage response pathways in the nematode C. elegans L Stergiou1 and MO Hengartner*,1 telangiectasia mutated kinase; ATR, ataxia telangiectasia-related kinase; Tel1, telomere length regulation 1; Chk1, checkpoint 1 Institute of Molecular Biology, University of Zurich, Winterthurerstrasse 190, kinase 1; Cdk, cyclin-dependent kinase; Cdc, cell division control; CH-8057 Zurich, Switzerland Apaf-1, apoptotic protease-activating factor-1; Bcl-2, B-cell * Corresponding author: MO Hengartner, Tel: þ 41 1 635 3140; Fax: þ 41 1 lymphoma 2; BH3, BCL-2 homology domain 3; PUMA, p53 635 6861; E-mail: [email protected] upregulated modulator of apoptosis; ced, cell death abnormal; Received 30.6.03; accepted 05.8.03 egl-1, egg-laying abnormal-1; mrt-2, mortal germ line-2; clk-2, Edited by G Melino clock gene; Spo 11, sporulation, meiosis-specific protein; msh, mismatch repair gene; cep-1, C. elegans p53 Abstract Genotoxic stress is a threat to our cells’ genome integrity. Introduction Failure to repair DNA lesions properly after the induction of cell proliferation arrest can lead to mutations or large-scale Living organisms expend considerable energy to preserve integrity of their genomes. Multiple mechanisms have evolved genomic instability. Because such changes may have to ensure the fidelity of genome duplication and to guarantee tumorigenic potential, damaged cells are often eliminated faithful partitioning of chromosomes at each cell division. via apoptosis. Loss of this apoptotic response is actually one Furthermore, cells are under the constant threat of DNA of the hallmarks of cancer.
    [Show full text]
  • VDAC1 Is Essential for Neurite Maintenance and the Inhibition Of
    www.nature.com/scientificreports OPEN VDAC1 is essential for neurite maintenance and the inhibition of its oligomerization protects Received: 4 July 2019 Accepted: 4 September 2019 spinal cord from demyelination Published: xx xx xxxx and facilitates locomotor function recovery after spinal cord injury Vera Paschon1, Beatriz Cintra Morena1, Felipe Fernandes Correia1, Giovanna Rossi Beltrame1, Gustavo Bispo dos Santos2, Alexandre Fogaça Cristante2 & Alexandre Hiroaki Kihara 1 During the progression of the neurodegenerative process, mitochondria participates in several intercellular signaling pathways. Voltage-dependent anion-selective channel 1 (VDAC1) is a mitochondrial porin involved in the cellular metabolism and apoptosis intrinsic pathway in many neuropathological processes. In spinal cord injury (SCI), after the primary cell death, a secondary response that comprises the release of pro-infammatory molecules triggers apoptosis, infammation, and demyelination, often leading to the loss of motor functions. Here, we investigated the functional role of VDAC1 in the neurodegeneration triggered by SCI. We frst determined that in vitro targeted ablation of VDAC1 by specifc morpholino antisense nucleotides (MOs) clearly promotes neurite retraction, whereas a pharmacological blocker of VDAC1 oligomerization (4, 4′-diisothiocyanatostilbene-2, 2′-disulfonic acid, DIDS), does not cause this efect. We next determined that, after SCI, VDAC1 undergoes conformational changes, including oligomerization and N-terminal exposition, which are important steps in the triggering of apoptotic signaling. Considering this, we investigated the efects of DIDS in vivo application after SCI. Interestingly, blockade of VDAC1 oligomerization decreases the number of apoptotic cells without interfering in the neuroinfammatory response. DIDS attenuates the massive oligodendrocyte cell death, subserving undisputable motor function recovery. Taken together, our results suggest that the prevention of VDAC1 oligomerization might be benefcial for the clinical treatment of SCI.
    [Show full text]
  • The Pseudo-Caspase FLIP(L) Regulates Cell Fate Following P53 Activation
    The pseudo-caspase FLIP(L) regulates cell fate following p53 activation Andrea Leesa,1, Alexander J. McIntyrea,1, Nyree T. Crawforda, Fiammetta Falconea, Christopher McCanna, Caitriona Holohana, Gerard P. Quinna, Jamie Z. Robertsa, Tamas Sesslera, Peter F. Gallaghera, Gemma M. A. Gregga, Katherine McAllistera, Kirsty M. McLaughlina, Wendy L. Allena, Laurence J. Eganb, Aideen E. Ryanb,c, Melissa J. Labonte-Wilsona, Philip D. Dunnea, Mark Wappetta, Vicky M. Coylea, Patrick G. Johnstona, Emma M. Kerra, Daniel B. Longleya,2,3, and Simon S. McDadea,2,3 aPatrick G Johnston Centre for Cancer Research, Queen’s University Belfast, Belfast, Northern Ireland BT9 7BL, United Kingdom; bDiscipline of Pharmacology & Therapeutics, Lambe Institute for Translational Research, School of Medicine, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland; and cRegenerative Medicine Institute, College of Medicine, Nursing and Health Sciences, National University of Ireland Galway, Galway, Ireland Edited by Karen H. Vousden, Francis Crick Institute, London, United Kingdom, and approved June 8, 2020 (received for review February 12, 2020) p53 is the most frequently mutated, well-studied tumor-suppressor switch from cell-cycle arrest to cell death induction remain gene, yet the molecular basis of the switch from p53-induced cell- poorly understood, although p53-mediated transcriptional up- cycle arrest to apoptosis remains poorly understood. Using a combi- regulation of PUMA has been suggested to be crucial in a nation of transcriptomics and functional genomics, we unexpectedly number of studies (10, 11). identified a nodal role for the caspase-8 paralog and only human Despite p53/TP53 being the most frequently mutated gene in pseudo-caspase, FLIP(L), in regulating this switch.
    [Show full text]
  • The Puzzling Interplay Between P53 and Sp1 - Full Text
    7/20/2021 Aging | The puzzling interplay between p53 and Sp1 - Full Text Editorial Volume 9, Issue 5 pp 1355—1356 The puzzling interplay between p53 and Sp1 Ariella Oppenheim1 , Galit Lahav2 1 Department of Hematology, Hebrew University Faculty of Medicine, Jerusalem 91120, Israel 2 Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA Received: May 4, 2017 Published: May 9, 2017 https://doi.org/10.18632/aging.101238 How to Cite Copyright: Oppenheim and Lahav. This is an open‐access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited The paradigm tumor suppressor protein p53 was initially discovered in the Seventies by a number of investigators as a protein that was tightly bound to SV40 large T-antigen, a “contaminant” during T-antigen purification [1]. Its role as a tumor suppressor was realized only a few years later, when it was found that it is absent or mutated in many tumors. Since then p53 has been described as the “guardian of the genome”, due to its central role in keeping genome integrity in response to genotoxic stress as well as many other insults [2]. Specificity Factor 1, Sp1, was the first mammalian transcription factor to be purified and characterized by Dynan and Tjian in the early Eighties. Sp1 is overexpressed in many types of cancer, including those carrying wild-type p53. Sp1 therefore is considered as a ‘hallmark of cancer’ and a candidate target for cancer therapy [3].
    [Show full text]
  • Caspase Activation & Apoptosis
    RnDSy-lu-2945 Caspase Activation & Apoptosis Extrinsic & Intrinsic Pathways of Caspase Activation CASPASE CLEAVAGE & ACTIVATION Caspases are a family of aspartate-specific, cysteine proteases that serve as the primary mediators of Pro-Domain Large Subunit (p20) Small Subunit (p10) apoptosis. Mammalian caspases can be subdivided into three functional groups, apoptotic initiator TRAIL Pro-Domain α chain β chain caspases (Caspase-2, -8, -9, -10), apoptotic effector caspases (Caspase-3, -6, -7), and caspases involved Asp-x Asp-x Proteolytic cleavage in inflammatory cytokine processing (Caspase-1, -4, -5, 11, and -12L/12S). All caspases are synthesized α chain as inactive zymogens containing a variable length pro-domain, followed by a large (20 kDa) and a small Fas Ligand TRAIL R1 Pro-Domain β chain TRAIL R2 Heterotetramer Formation (10 kDa) subunit. FADD FADD α chain α chain Pro-caspase-8, -10 Active caspase Pro-caspase-8, -10 TWEAK β chain Apoptotic caspases are activated upon the receipt of either an extrinsic or an intrinsic death signal. The Fas/CD95 extrinsic pathway (green arrows) is initiated by ligand binding to cell surface death receptors (TNF RI, Fas/ MAMMALIAN CASPASE DOMAINS & CLEAVAGE SITES FADD FADD TNF-α APOPTOTIC CASPASES CD95, DR3, TRAIL R1/DR4, TRAIL R2/DR5) followed by receptor oligomerization and cleavage of Pro- Extrinsic Pathway DR3 (or another TWEAK R) INITIATOR CASPASES 152 316 331 Pro-caspase-8, -10 Pro-caspase-8, -10 1 435 caspase-8 and -10. Activation of Caspase-8 and Caspase-10 results in the cleavage of BID and Caspase-2 CARD TRADD FLIP TRADD downstream effector caspases.
    [Show full text]
  • Thirty Years of BCL-2: Translating Cell Death Discoveries Into Novel Cancer
    PERSPECTIVES normal physiology and cancer remains TIMELINE unclear, and is beyond the scope of this article (for a review on these topics, see Thirty years of BCL-2: translating REF. 10). This Timeline article focuses on key advances in our understanding of the function of the BCL-2 protein family in cell death discoveries into novel cell death, in the development of cancer, cancer therapies and as targets in cancer therapy. Early studies on apoptosis Alex R. D. Delbridge, Stephanie Grabow, Andreas Strasser and David L. Vaux In their 1972 paper that adopted the word ‘apoptosis’ to describe a physiological Abstract | The ‘hallmarks of cancer’ are generally accepted as a set of genetic and process of cellular suicide, Kerr and epigenetic alterations that a normal cell must accrue to transform into a fully colleagues11 recognized the presence malignant cancer. It follows that therapies designed to counter these alterations of apoptotic cells in tissue sections of miht e effective as anti-cancer strateies ver the past 3 years, research on certain human cancers. Accordingly, the BCL-2-regulated apoptotic pathway has led to the development of they proposed that increasing the rate of apoptosis of neoplastic cells relative to their small-molecule compounds, nown as BH3-mimetics, that ind to pro-survival rate of production could potentially be BCL-2 proteins to directly activate apoptosis of malignant cells. This Timeline therapeutic. However, interest in cell death article focuses on the discovery and study of BCL-2, the wider BCL-2 protein family and its role in cancer languished until the and, specifically, its roles in cancer development and therapy late 1980s, when genetic abnormalities that prevented cell death were directly linked to malignancy in humans.
    [Show full text]
  • The Ups and Downs of P53: Proc
    PERSPECTIVES 155. Akira, S. & Takeda, K. Toll-like receptor signalling. Nature Rev. Immunol. 4, 499–511 (2004). OPINION 156. Tsenova, L., Bergtold, A., Freedman, V. H., Young, R. A. & Kaplan, G. Tumour necrosis factor α is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system. The ups and downs of p53: Proc. Natl Acad. Sci. USA 96, 5657–5662 (1999). 157. Schluter, D. et al. Both lymphotoxin-α and TNF are crucial for control of Toxoplasma gondii in the central nervous system. J. Immunol. 170, 6172–6182 (2003). understanding protein dynamics 158. Pasparakis, M. et al. Peyer’s patch organogenesis is intact yet formation of B lymphocyte follicles is defective in peripheral lymphoid organs of mice deficient for in single cells tumor necrosis factor and its 55-kDa receptor. Proc. Natl Acad. Sci. USA 94, 6319–6323 (1997). 159. Kuprash, D. V. et al. Novel tumor necrosis factor- Eric Batchelor, Alexander Loewer and Galit Lahav knockout mice that lack Peyer’s patches. Eur. J. Immunol. 35, 1592–1600 (2005). 160. Grivennikov, S. I. et al. Distinct and nonredundant Abstract | Cells living in a complex environment must constantly detect, process in vivo functions of TNF produced by T cells and macrophages/neutrophils: protective and deleterious and appropriately respond to changing signals. Therefore, all cellular information effects. Immunity 22, 93–104 (2005). 161. Beutler, B. et al. Identity of tumour necrosis factor and processing is dynamic in nature. As a consequence, understanding the process of the macrophage-secreted factor cachetin. Nature 316, signal transduction often requires detailed quantitative analysis of dynamic 552–554 (1985).
    [Show full text]
  • Apoptosome Dependent Caspase-3 Activation Pathway Is Non-Redundant and Necessary for Apoptosis in Sympathetic Neurons
    Cell Death and Differentiation (2007) 14, 625–633 & 2007 Nature Publishing Group All rights reserved 1350-9047/07 $30.00 www.nature.com/cdd Apoptosome dependent caspase-3 activation pathway is non-redundant and necessary for apoptosis in sympathetic neurons KM Wright1,3, AE Vaughn2,3 and M Deshmukh*,1,2,3 Although sympathetic neurons are a well-studied model for neuronal apoptosis, the role of the apoptosome in activating caspases in these neurons remains debated. We find that the ability of sympathetic neurons to undergo apoptosis in response to nerve growth factor (NGF) deprivation is completely dependent on having an intact apoptosome pathway. Genetic deletion of Apaf-1, caspase-9, or caspase-3 prevents apoptosis after NGF deprivation, and importantly, allows these neurons to recover and survive long-term following readdition of NGF. The inability of caspase-3 deficient sympathetic neurons to undergo apoptosis is particularly striking, as apoptosis in dermal fibroblasts and cortical neurons proceeds even in the absence of caspase-3. Our results show that in contrast to dermal fibroblasts and cortical neurons, sympathetic neurons express no detectable levels of caspase-7. The strict requirement for an intact apoptosome, coupled with a lack of effector caspase redundancy, provides sympathetic neurons with a markedly increased control over their apoptotic pathway. Cell Death and Differentiation (2007) 14, 625–633. doi:10.1038/sj.cdd.4402024; published online 25 August 2006 Apoptosis, a form of programmed cell death, is a critical multimeric complex termed the apoptosome.6 The apopto- component of normal organism development. The major some-mediated activation of caspases is initiated by the molecular events that occur during apoptosis have been release of cytochrome c from the mitochondria, a process that identified by many elegant biochemical studies, using both cell is regulated by interactions between the antiapoptotic and free systems and cell lines.1 However, differences in the proapoptotic members of the Bcl-2 family of proteins.
    [Show full text]
  • Apaf-1/Cytochrome C Apoptosome: an Essential Initiator of Caspase Activation Or Just a Sideshow?
    Cell Death and Differentiation (2003) 10, 16–18 & 2003 Nature Publishing Group All rights reserved 1350-9047/03 $25.00 www.nature.com/cdd News and Commentary Apaf-1/cytochrome c apoptosome: an essential initiator of caspase activation or just a sideshow? B Baliga1 and S Kumar*,1 1 or caspase-9-deficient cells than in their wild-type counter- parts, the cells show little defect in their ability to undergo 1 Hanson Institute, Frome Road, Adelaide, SA 5000, Australia apoptosis in response to physiological and pathological * Corresponding author: E-mail: [email protected] stimuli.7 Importantly, while Apaf-1 and caspase-9 are dis- pensable for cell death, BCL-2 does confer a survival Cell Death and Differentiation (2003) 10, 16–18. doi:10.1038/ advantage to these deficient cells. Thus, in an experimental sj.cdd.4401166 system where cytochrome c has no involvement, BCL-2 can still protect against cell death, arguing against the widely held view that BCL-2 solely protects cell death by preventing the Caspase activation in mammalian cells is mediated via two release of apoptogenic factors from mitochondria and main- main routes, often referred to as ‘the intrinsic pathway’ and taining mitochondrial membrane integrity.4 In addition, the ‘the extrinsic pathway’.1 The extrinsic pathway of apoptosis is authors show that treating cells with several highly specific induced by ligand-mediated activation of the tumour necrosis broad-spectrum caspase inhibitors produced a similar pheno- factor (TNF) family of cell surface receptors. A large protein
    [Show full text]